Drug Treatments for Acid Reflux are Facing new FDA Scrutiny

The agency is investigating if PPIs negatively affect the heart, although early analysis suggests not. Also, a recent study associates H2 blockers with cognitive decline. The effects of Food and Drug Administration action and a study published last month have combined to bring attention to possible adverse effects of proton pump inhibitors, the drugs commonly used to treat acid reflux.

MORE ON THIS TOPIC